Femasys (FEMY) Competitors $1.11 0.00 (0.00%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends FEMY vs. FONR, GUTS, LNSR, MLSS, MGRM, EDAP, HYPR, VANI, STIM, and NSPRShould you be buying Femasys stock or one of its competitors? The main competitors of Femasys include FONAR (FONR), Fractyl Health (GUTS), LENSAR (LNSR), Milestone Scientific (MLSS), Monogram Orthopaedics (MGRM), Edap Tms (EDAP), Hyperfine (HYPR), Vivani Medical (VANI), Neuronetics (STIM), and InspireMD (NSPR). These companies are all part of the "medical equipment" industry. Femasys vs. FONAR Fractyl Health LENSAR Milestone Scientific Monogram Orthopaedics Edap Tms Hyperfine Vivani Medical Neuronetics InspireMD FONAR (NASDAQ:FONR) and Femasys (NASDAQ:FEMY) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, media sentiment, community ranking, valuation, earnings, dividends, institutional ownership, profitability and analyst recommendations. Which has better earnings and valuation, FONR or FEMY? FONAR has higher revenue and earnings than Femasys. Femasys is trading at a lower price-to-earnings ratio than FONAR, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFONAR$102.88M0.94$10.57M$1.4010.87Femasys$1.07M23.76-$14.25M-$0.81-1.37 Do analysts prefer FONR or FEMY? Femasys has a consensus price target of $10.00, indicating a potential upside of 800.90%. Given Femasys' stronger consensus rating and higher possible upside, analysts clearly believe Femasys is more favorable than FONAR.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score FONAR 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Femasys 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do insiders and institutionals have more ownership in FONR or FEMY? 50.6% of FONAR shares are owned by institutional investors. Comparatively, 65.3% of Femasys shares are owned by institutional investors. 2.2% of FONAR shares are owned by company insiders. Comparatively, 12.3% of Femasys shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Does the MarketBeat Community favor FONR or FEMY? FONAR received 149 more outperform votes than Femasys when rated by MarketBeat users. Likewise, 74.69% of users gave FONAR an outperform vote while only 72.09% of users gave Femasys an outperform vote. CompanyUnderperformOutperformFONAROutperform Votes18074.69% Underperform Votes6125.31% FemasysOutperform Votes3172.09% Underperform Votes1227.91% Is FONR or FEMY more profitable? FONAR has a net margin of 9.41% compared to Femasys' net margin of -1,435.77%. FONAR's return on equity of 6.10% beat Femasys' return on equity.Company Net Margins Return on Equity Return on Assets FONAR9.41% 6.10% 4.58% Femasys -1,435.77%-141.49%-82.30% Does the media favor FONR or FEMY? In the previous week, FONAR and FONAR both had 1 articles in the media. FONAR's average media sentiment score of 0.47 beat Femasys' score of 0.33 indicating that FONAR is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment FONAR 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Femasys 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more risk and volatility, FONR or FEMY? FONAR has a beta of 1.22, indicating that its share price is 22% more volatile than the S&P 500. Comparatively, Femasys has a beta of -2.82, indicating that its share price is 382% less volatile than the S&P 500. SummaryFONAR beats Femasys on 11 of the 17 factors compared between the two stocks. Get Femasys News Delivered to You Automatically Sign up to receive the latest news and ratings for FEMY and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FEMY vs. The Competition Export to ExcelMetricFemasysSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$25.42M$4.71B$5.21B$9.14BDividend YieldN/A47.30%5.13%4.02%P/E Ratio-1.3726.2989.3417.36Price / Sales23.7658.291,240.0477.11Price / CashN/A50.1443.7535.97Price / Book1.317.795.314.79Net Income-$14.25M$13.87M$122.54M$225.00M7 Day Performance5.71%1.53%0.59%2.62%1 Month Performance1.83%10.34%2.55%3.81%1 Year Performance38.75%32.32%25.29%20.10% Femasys Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FEMYFemasys3.5841 of 5 stars$1.11flat$10.00+800.9%+37.0%$25.42M$1.07M-1.3730FONRFONAR1.32 of 5 stars$15.13-0.7%N/A-20.2%$95.74M$102.01M10.81480Short Interest ↑News CoverageGUTSFractyl Health1.6831 of 5 stars$1.95+5.4%$22.00+1,028.2%N/A$93.79M$97,000.00-0.16102Short Interest ↑News CoveragePositive NewsGap UpHigh Trading VolumeLNSRLENSAR0.6487 of 5 stars$8.06-2.3%$8.00-0.7%+133.1%$93.62M$48.87M-5.52110MLSSMilestone Scientific0.7523 of 5 stars$1.08-8.5%$1.25+15.7%+96.7%$84.12M$8.88M-15.4330MGRMMonogram Orthopaedics3.5232 of 5 stars$2.45-2.0%$4.00+63.3%-19.2%$84.06M$364,999.00-5.2128Positive NewsEDAPEdap Tms3.4291 of 5 stars$2.07-1.4%$19.00+817.9%-64.5%$76.81M$63.41M-3.18307HYPRHyperfine2.0021 of 5 stars$0.98+4.3%$1.60+63.3%+2.0%$71.49M$13.26M-1.72190VANIVivani Medical3.4946 of 5 stars$1.20-0.8%$3.00+150.0%+17.6%$71.08MN/A-2.6720Positive NewsSTIMNeuronetics3.2663 of 5 stars$2.34+36.8%$4.67+99.4%-25.9%$71.01M$72.71M-1.90180Gap UpHigh Trading VolumeNSPRInspireMD2.1214 of 5 stars$2.65-4.0%$4.75+79.2%-13.7%$69.12M$6.82M-3.5350Gap Down Related Companies and Tools Related Companies FONAR Alternatives Fractyl Health Alternatives LENSAR Alternatives Milestone Scientific Alternatives Monogram Orthopaedics Alternatives Edap Tms Alternatives Hyperfine Alternatives Vivani Medical Alternatives Neuronetics Alternatives InspireMD Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:FEMY) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMust-See: 5-Second Trump PredictionPresident Trump's prediction is about to become a reality... Opening a rare window of opportunity for you t...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredWarren Buffett Bets $40 Billion—You Can Get in for $20I call it "The Last Retirement Stock You'll Ever Need." Warren Buffett himself owns $40 billion of stock in...Behind the Markets | SponsoredKamala’s final humiliation The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware ...Porter & Company | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Femasys Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Femasys With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.